IL1RAP and Ewing sarcoma: Human anti-IL1RAP antibodies are able to induce potent antibody-dependent cellular cytotoxicity against Ewing sarcoma cells [46]; for this reason, IL1RAP expression has gained attention from an immunotherapeutic perspective.